rs28383048

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 1P and 9B. PP2BP4_StrongBP6BS2

The NM_000348.4(SRD5A2):​c.337C>G​(p.Leu113Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000341 in 1,597,022 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 9/11 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0018 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00019 ( 1 hom. )

Consequence

SRD5A2
NM_000348.4 missense

Scores

8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: -0.518

Publications

6 publications found
Variant links:
Genes affected
SRD5A2 (HGNC:11285): (steroid 5 alpha-reductase 2) This gene encodes a microsomal protein expressed at high levels in androgen-sensitive tissues such as the prostate. The encoded protein is active at acidic pH and is sensitive to the 4-azasteroid inhibitor finasteride. Deficiencies in this gene can result in male pseudohermaphroditism, specifically pseudovaginal perineoscrotal hypospadias (PPSH). [provided by RefSeq, Jul 2008]
SRD5A2 Gene-Disease associations (from GenCC):
  • 46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 40 curated pathogenic missense variants (we use a threshold of 10). The gene has 9 curated benign missense variants. Trascript score misZ: -0.88748 (below the threshold of 3.09). GenCC associations: The gene is linked to 46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency.
BP4
Computational evidence support a benign effect (MetaRNN=0.013136238).
BP6
Variant 2-31533711-G-C is Benign according to our data. Variant chr2-31533711-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 459636.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SRD5A2NM_000348.4 linkc.337C>G p.Leu113Val missense_variant Exon 2 of 5 ENST00000622030.2 NP_000339.2 P31213
SRD5A2XM_011533069.3 linkc.115C>G p.Leu39Val missense_variant Exon 2 of 5 XP_011531371.1
SRD5A2XM_011533072.3 linkc.82C>G p.Leu28Val missense_variant Exon 4 of 7 XP_011531374.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SRD5A2ENST00000622030.2 linkc.337C>G p.Leu113Val missense_variant Exon 2 of 5 1 NM_000348.4 ENSP00000477587.1 P31213
ENSG00000228563ENST00000435713.1 linkn.255+6011G>C intron_variant Intron 2 of 2 3

Frequencies

GnomAD3 genomes
AF:
0.00178
AC:
271
AN:
152206
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00632
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.000420
AC:
94
AN:
223596
AF XY:
0.000317
show subpopulations
Gnomad AFR exome
AF:
0.00643
Gnomad AMR exome
AF:
0.0000941
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000300
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000190
AC:
274
AN:
1444698
Hom.:
1
Cov.:
31
AF XY:
0.000179
AC XY:
128
AN XY:
716572
show subpopulations
African (AFR)
AF:
0.00623
AC:
207
AN:
33220
American (AMR)
AF:
0.000188
AC:
8
AN:
42464
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25746
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39104
South Asian (SAS)
AF:
0.0000121
AC:
1
AN:
82520
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52506
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5752
European-Non Finnish (NFE)
AF:
0.00000816
AC:
9
AN:
1103526
Other (OTH)
AF:
0.000718
AC:
43
AN:
59860
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
15
30
45
60
75
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00178
AC:
271
AN:
152324
Hom.:
2
Cov.:
32
AF XY:
0.00158
AC XY:
118
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.00630
AC:
262
AN:
41580
American (AMR)
AF:
0.000262
AC:
4
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68028
Other (OTH)
AF:
0.00142
AC:
3
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
15
30
45
60
75
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000254
Hom.:
1
Bravo
AF:
0.00165
ESP6500AA
AF:
0.00593
AC:
23
ESP6500EA
AF:
0.000120
AC:
1
ExAC
AF:
0.000530
AC:
64
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1
Feb 08, 2021
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Missense variants in this gene are often considered pathogenic (Stenson et al., 2014); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 30238986, 22371315, 10458450, 21037542) -

3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency Benign:1
Sep 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
0.013
DANN
Benign
0.56
FATHMM_MKL
Benign
0.024
N
MetaRNN
Benign
0.013
T
PhyloP100
-0.52
PrimateAI
Benign
0.32
T
Sift4G
Benign
0.46
T
Vest4
0.70
MVP
0.29
GERP RS
-3.8
gMVP
0.39
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28383048; hg19: chr2-31758781; API